Atlas Trials

Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF)

Clinical trial NCT02343445 · COMPLETED

Trial details

NCT number
NCT02343445
Sponsor
Parion Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2015-04-01
Primary completion
2016-02-01
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.